Biocon Biologics Archives - Express Pharma

Biocon Biologics sells branded formulations biz to Eris Lifesciences for INR12.42 bn

Biocon Biologics gets US market entry date for Bmab 1200, a proposed biosimilar to Stelara

Biocon included in S&P Global Sustainability Yearbook 2024

Biocon Biologics Partners with Sandoz Australia for Trastuzumab and Bevacizumab

Biocon Biologics successfully integrates acquired biosimilars business across 120 countries

Biocon Biologics gets MHRA approval for YESAFILI, biosimilar Aflibercept

Biocon Biologics signs pact with Eris Lifesciences for divesture of dermatology and nephrology branded formulations business units in India

Biocon at No. 8 in Science Magazine’s list of best employers in biotech and pharma

Biocon Biologics gets EC approval for YESAFILI, biosimilar Aflibercept

Kiran Mazumdar-Shaw appointed member of Court of Regents at RCSed